These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12188011)

  • 1. Hepatitis A seroprevalence in Slovene travellers.
    Socan M; Kraigher A; Fiser-Marinic N
    Eur J Epidemiol; 2001; 17(10):925-6. PubMed ID: 12188011
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of hepatitis A antibodies in travellers at the Edmonton Travellers' Health Clinic--Alberta.
    Kocuipchyk FR; Lightfoot PJ; Stout I; Devine RD
    Can Commun Dis Rep; 1995 Apr; 21(8):65-71. PubMed ID: 7787817
    [No Abstract]   [Full Text] [Related]  

  • 3. Declining hepatitis A antibody seroprevalence in the Korean military personnel.
    Lee CS; Kwon KS; Koh DH; Youm JH; Gwack J; Lee JH
    Jpn J Infect Dis; 2010 May; 63(3):192-4. PubMed ID: 20495272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of screening serology in anti-hepatitis A vaccination of travelers].
    Landry P; Darioli R
    Schweiz Med Wochenschr; 1998 Apr; 128(15):581-5. PubMed ID: 9606799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis A antibodies in Swiss travellers.
    Studer S; Joller-Jemelka HI; Steffen R; Grob PJ
    Eur J Epidemiol; 1993 Jan; 9(1):50-4. PubMed ID: 8386103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hepatitis A in travellers.
    Steffen R
    Vaccine; 1992; 10 Suppl 1():S69-72. PubMed ID: 1335664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The seroprevalence of hepatitis A and B in people testing positive for hepatitis C.
    Kiefer LA; Honish A; Predy G; Talbot JA
    CMAJ; 2000 Jan; 162(2):207-8. PubMed ID: 10674054
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.
    Schwartz E; Raveh D
    Int J Epidemiol; 1998 Feb; 27(1):118-20. PubMed ID: 9563704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of hepatitis A virus antibody among children and young adults in Bangkok.
    Pancharoen C; Mekmullica J; Kasempimolporn S; Thisyakorn U; Wilde H
    J Med Assoc Thai; 2001 Oct; 84(10):1477-80. PubMed ID: 11804259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Seroprevalence of Hepatitis A And E Viruses in Blood Donors from Wielkopolska Region, West-Central Poland.
    Bura M; Łagiedo-Żelazowska M; Michalak M; Sikora J; Mozer-Lisewska I
    Pol J Microbiol; 2018 Mar; 67(1):113-115. PubMed ID: 30015433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis A antibodies in hemophiliacs: preliminary results from the Southeastern Delta Hepatitis Study.
    Mah MW; Royce RA; Rathouz PJ; Wang JG; White GC; Janco RL; Hanna WT; Davis PC; Johnson CA; Poon MC
    Vox Sang; 1994; 67 Suppl 1():21-2; discussion 23. PubMed ID: 8091730
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of antibodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience.
    Fock KM; Tay HH; Phua KB; Guan R; Chia SC; Chong R; Chee AE; Chew CN
    Singapore Med J; 1995 Feb; 36(1):26-7. PubMed ID: 7570129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area].
    Cesur S; Akin K; Doğaroğlu I; Birengel S; Balik I
    Mikrobiyol Bul; 2002 Jan; 36(1):79-83. PubMed ID: 12476770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis A antibodies in southeastern Spain: a population-based study.
    García-Fulgueiras A; Rodriguez T; Tormo MJ; Perez-Flores D; Chirlaque D; Navarro C
    Eur J Epidemiol; 1997 Jun; 13(4):481-3. PubMed ID: 9258557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis type E in Italy: a seroepidemiological survey. Study Group of Hepatitis E.
    Zanetti AR; Dawson GJ
    J Med Virol; 1994 Mar; 42(3):318-20. PubMed ID: 8006645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of travel on the seroprevalence of hepatitis A in children.
    Faillon S; Martinot A; Hau I; Puget A; Moulin F; Noel G; Guen CG; Lorrot M; Callamand P; Hue V; Meritet JF; Gendrel D; Dubos F
    J Clin Virol; 2013 Jan; 56(1):46-51. PubMed ID: 23127561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing risk profile of hepatitis A in The Netherlands: a comparison of seroprevalence in 1995-1996 and 2006-2007.
    Verhoef L; Boot HJ; Koopmans M; Mollema L; Van Der Klis F; Reimerink J; Van Pelt W
    Epidemiol Infect; 2011 Aug; 139(8):1172-80. PubMed ID: 21226987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.
    Dal-Ré R; García-Corbeira P; García-de-Lomas J
    J Med Virol; 2000 Apr; 60(4):363-6. PubMed ID: 10686017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R; Bosman A; de Zwart O
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody.
    Wang SM; Liu CC; Huang YS; Yang YJ; Lei HY
    J Med Virol; 2001 Jun; 64(2):104-8. PubMed ID: 11360241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.